術前の心肺運動検査で特定された,心不全に関連した炭水化物抗原125の上昇

R G Davies¹, F Fiorini¹, D M Bailey²

¹Department of Anaesthesia University Hospital of Wales Cardiff UK.

Anaesthesia reports

|August 29, 2025

まとめ

炭水化物抗原125の上昇はしばしば癌と関連付けられ心不全を示します心肺運動検査は無症状の心不全の診断に役立ち,治療と不必要な手術を回避しました.

科学分野:

心臓病科
腫瘍学
診断医学

背景:

患者の罹病率と死亡率に影響を与える.
ナトリウレチンペプチドは従来の心不全のバイオマーカーであるが,高炭水化物抗原125 (CA-125) も心不全,特に右側または保存されたエジェクション分子を示すことができる.
CA-125は一般的に卵巣がんと関連しており,診断に問題がある.

研究の目的:

画像とCA-125値の上昇に基づいて,卵巣がんの診断を想定した患者の治療に成功したことを報告する.
手術前評価中に無症状の心不全を特定する際の心肺運動検査 (CPET) の有用性を説明する.
心不全の管理におけるバイオマーカーとしてのCA-125の役割と悪性腫瘍との差異化の可能性を強調する.

主な方法:

卵巣がんの疑いによる手術前評価の一環として,71歳の女性がCPETを受けた.
CPETによる最大値以下では,有意で無症状の心不全が確認されました.
心臓病学による医療最適化が開始されました.

主要な成果:

CPETでは無症状の心不全が明らかになり手術を延期した.
CA-125濃度が正常化して卵巣がんの診断を否定した
患者は大きな腹腔外科手術を避けました

結論:

このケースは,特に悪性腫瘍が疑われる場合,CA-125値が上昇した患者の心不全の重要性を強調しています.
CPETは心臓機能不全などの隠れた併発症を診断し,手術前のリスクの階層化と患者の管理を改善するための貴重なツールです.
バイオマーカーの解釈には,誤診と不必要な介入を避けるために,CPETのような診断検査を含む包括的な臨床文脈が必要です.

キーワード:

CA125 について運動テスト心不全卵巣腫瘍

さらに関連する動画

05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

9.4K

04:20

Integration of Brain Tissue Saturation Monitoring in Cardiopulmonary Exercise Testing in Patients with Heart Failure

Published on: October 1, 2019

5.9K

関連する概念動画

01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...

01:28

Cardiac Catheterization I: Pre-Procedure Overview

153

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...

153

01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...

01:26

Exercise Stress Test

489

Introduction
Exercise stress testing, commonly known as a treadmill test, is a noninvasive procedure used to evaluate cardiovascular function and diagnose heart conditions.
Definition
An exercise stress test measures the heart's response to exertion using a treadmill or stationary bicycle. Chest electrodes record the heart's electrical activity through an ECG, and blood pressure is monitored regularly.
Purposes

489

01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...